RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • 임상시험심사위원회와 기관생명윤리심의위원회의 개선방향에 관한 고찰

        백수진,권복규 이화여자대학교 생명의료법연구소 2007 생명윤리정책연구 Vol.1 No.2

        Institutional Review Board and Institutional Bioethics Review Board are primary Research Ethics Committees in Korea. Institutional Review Board(IRB) is the mandatory organization which reviews and has authority to approve, secure approval, or disapprove IND (Investigational New Drug) clinical research activities conducted in the institution( most hospitals) covered by Korea Good Clinical Practice(KGCP). Institutional Bioethics Review Board(IBRB) is the committee which reviews research activities conducted in the institution(Institutions related to Production Embryo, Cloning by somatic cell nuclear transfer, Dealing with Gene, and Human Tissue Bank etc.) regulated by the Law on Bioethics and Biosafety. IRB and IBRB in Korea have a similar structure and function. Nevertheless, there are some differences. IBRBs focus on the review of ethical perspective of the particular scientific research, whereas IRBs emphasize on the protection of the human subject. These roles and status of these two committees play an important role in determining how these two committees should be managed in both legal and institutional frameworks. This study, through the comparison of IRB and IBRB, seek to find a way to prepare standard of practice, development of educational program for investigators and IRB members, development of accreditation program, which will contribute to the promotion of IRB.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼